Simple cloning of large natural product biosynthetic gene cluster by CRISPR/Cas12a-mediated fast direct capturing strategy
Mindong Liang,Leshi Liu,Weishan Wang,Xiaoqian Zeng,Jiakun Liu,Loganathan Karthik,Guoliang Zhu,Linquan Bai,Chengjian Hou,Xiangyin Chen,Liming Ouyang,Xueting Liu,Bin Hu,Xuekui Xia,Yaojun Tong,Chunbo Lou,Gil Alterovitz,Gao-Yi Tan,Li-Xin Zhang
DOI: https://doi.org/10.1101/2020.06.25.170191
2020-01-01
Abstract:Directly cloning of biosynthetic gene clusters (BGCs) from even unculturable microbial genomes revolutionized nature products-based drug discovery. However, it is still very challenging to efficiently cloning, for example, the large (e.g. > 80kb) BGCs, especially for samples with high GC content in Streptomyces. In this study, by combining the advantages of CRISPR/Cas12a cleavage and bacterial artificial chromosome (BAC) library construction, we developed a simple, fast yet efficient in vitro platform for direct cloning of large BGCs based on CRISPR/Cas12a, named CAT-FISHING (CRISPR/Cas12a-mediated fast direct biosynthetic gene cluster cloning). It was demonstrated by the efficient direct cloning of large DNA fragments from bacterial artificial chromosomes or high GC (>70%) Streptomyces genomic DNA. Moreover, surugamides, encoded by a captured 87-kb gene cluster, was expressed and identified in a cluster-free Streptomyces chassis. These results indicate that CAT-FISHING is now poised to revolutionize bioactive small molecules (BSMs) drug discovery and lead a renaissance of interest in microorganisms as a source of BSMs for drug development.